You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

OMEGA-3-ACID ETHYL ESTERS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Omega-3-acid Ethyl Esters patents expire, and when can generic versions of Omega-3-acid Ethyl Esters launch?

Omega-3-acid Ethyl Esters is a drug marketed by Amneal Pharms, Apotex, Ascent Pharms Inc, Chartwell, Cspc-nbp Pharm, GLW, Mankind Pharma, Puracap Pharm Llc, Sofgen Pharms, Strides Pharma, Sun Pharm, Wilshire Pharms Inc, and Zydus Lifesciences. and is included in fifteen NDAs.

The generic ingredient in OMEGA-3-ACID ETHYL ESTERS is omega-3-acid ethyl esters. There are thirteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the omega-3-acid ethyl esters profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Omega-3-acid Ethyl Esters

A generic version of OMEGA-3-ACID ETHYL ESTERS was approved as omega-3-acid ethyl esters by GLW on April 7th, 2014.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OMEGA-3-ACID ETHYL ESTERS?
  • What are the global sales for OMEGA-3-ACID ETHYL ESTERS?
  • What is Average Wholesale Price for OMEGA-3-ACID ETHYL ESTERS?
Drug patent expirations by year for OMEGA-3-ACID ETHYL ESTERS
Drug Prices for OMEGA-3-ACID ETHYL ESTERS

See drug prices for OMEGA-3-ACID ETHYL ESTERS

Drug Sales Revenue Trends for OMEGA-3-ACID ETHYL ESTERS

See drug sales revenues for OMEGA-3-ACID ETHYL ESTERS

Recent Clinical Trials for OMEGA-3-ACID ETHYL ESTERS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2
The University of Texas Health Science Center at San AntonioEarly Phase 1
National Center for Advancing Translational Sciences (NCATS)Early Phase 1

See all OMEGA-3-ACID ETHYL ESTERS clinical trials

Pharmacology for OMEGA-3-ACID ETHYL ESTERS
Drug ClassOmega-3 Fatty Acid
Paragraph IV (Patent) Challenges for OMEGA-3-ACID ETHYL ESTERS
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
LOVAZA Capsules omega-3-acid ethyl esters 1 g 021654 3 2008-11-10

US Patents and Regulatory Information for OMEGA-3-ACID ETHYL ESTERS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 204940-001 Nov 27, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glw OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 212504-001 Aug 19, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 206455-001 Aug 7, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 203893-001 Sep 19, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mankind Pharma OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 215458-001 Nov 15, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wilshire Pharms Inc OMEGA-3-ACID ETHYL ESTERS omega-3-acid ethyl esters CAPSULE;ORAL 211345-001 Dec 7, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.